CJC-1295 / Ipamorelin (No DAC)
Combination of CJC-1295 (GHRH analog, No DAC) and Ipamorelin (selective GHRP). Researched alongside GLP-1 agonists in body composition studies — GLP-1s reduce energy intake while GH secretagogues support lean mass preservation during caloric deficit. CJC-1295 stimulates pulsatile GH release; Ipamorelin provides selectivity without cortisol or prolactin elevation.
Chemical Information
Chemical Name: CJC-1295 (No DAC) + Ipamorelin
Related Products
GLP-1 C + GLP-1 S
Combination vial of GLP-1 C (Cagrilintide — long-acting amylin analog) and GLP-1 S (Semaglutide). Mirrors the CagriSema combination studied in Novo Nordisk's REDEFINE trials, which showed greater weight reduction than semaglutide monotherapy. Research applications include dual amylin/GLP-1 mechanism studies and satiety pathway investigation.
CJC-1295 / Ipamorelin (No DAC)
$50.00